Healthcare M&A Transactions in 2024+ Under Heightened State and Federal Scrutiny: New Reporting Requirements

Ms. Ivey is a healthcare transactions attorney in Holland & Knight's Nashville office. She assists healthcare clients with a wide range of strategic transactions, including recapitalizations, leveraged buyouts, mergers, acquisitions, joint ventures and divestitures involving physician practices, behavioral healthcare facilities, dental practices and other healthcare platforms. Ms. Ivey also represents clients in the sale of portfolio companies and investments involving private equity and other strategic buyers. She works extensively with physician practice management companies and dental support organizations operating across the United States. Ms. Ivey's experience includes transactional matters across the healthcare spectrum including dental, orthodontics, women's health, dermatology, chiropractic medicine, physical therapy, optometry and ophthalmology. 

Mr. Wolford is a healthcare attorney in Holland & Knight's Nashville office. He assists a wide range of healthcare clients with regulatory compliance, day-to-day operations, Stark Law and Anti-Kickback Statute (AKS) analysis, contract negotiations and other complex regulatory issues. Mr. Wolford's experience includes a deep understanding of the day-to-day operational challenges that healthcare owners and operators face and how to incorporate healthcare regulatory compliance in a manner that is straightforward and understandable. He has a keen insight on balancing the business objectives of his clients with the often challenging operational and regulatory issues that can arise in various healthcare transactions and contractual negotiations with providers. Mr. Wolford also helps healthcare companies, investors and lenders to avoid and address legal and compliance issues related to the Stark Law, AKS, False Claims Act (FCA), Health Insurance Portability and Accountability Act (HIPAA), medical staff bylaws, licensure requirements, and other state and federal healthcare laws. Additionally, his experience includes providing direction and guidance following allegations or findings of significant non-compliance, whether that be leading internal investigations, submissions of self-disclosures, consulting on qui tam actions or providing compliance program review and development.

Mr. Saran regularly advises healthcare companies and private equity investors on mergers and acquisitions and public offerings in the healthcare and life science industries, including hospitals and healthcare systems, physician and dental practices, management/dental service organizations and digital health companies. He also has experience in assisting provider platforms with their growth strategy including add-on acquisitions, complex service arrangements and joint ventures. Mr. Saran’s regulatory practice helps clients navigate matters related to the corporate practice of medicine, fraud and abuse laws, HIPAA, the CARES Act/COVID-19 laws and healthcare licensure.